Published • loading... • Updated
Trump administration announces drug pricing deals with Teva, Astellas and others
The companies will offer lower prices tied to other wealthy countries and give state Medicaid programs discounts, the White House said.
- The Trump Administration announced new drug pricing deals with companies including Teva Pharmaceuticals to lower Medicaid medicine costs in the U.S. by aligning prices with other developed countries under the GENEROUS framework.
- Teva Pharmaceuticals committed to maintaining investment in scientific innovation and U.S. pharmaceutical manufacturing while supporting active pharmaceutical ingredient reserves for public health.
Insights by Ground AI
43 Articles
43 Articles
Trump announces deals with nine more drugmakers to cut U.S. prices
WASHINGTON — President Donald Trump announced Monday that nine additional drugmakers have agreed to sell medicines in the United States at “most-favored-nation” prices matching the lowest rates paid in other wealthy countries, expanding a signature effort he says will cut costs for Medicaid programs, cash-paying patients and future drug launches. The White House said the… The post Trump announces deals with nine more drugmakers to cut U.S. price…
Trump administration announces drug pricing deals with Teva, Astellas and others
U.S. President Donald Trump announced a new round of drug-pricing agreements with international pharmaceutical companies and some smaller biotechs on Monday, part of a push to make healthcare more affordable for Americans.
·London, United Kingdom
Read Full Article
Coverage Details
Total News Sources43
Leaning Left6Leaning Right10Center19Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 17%
C 54%
R 29%
Factuality
To view factuality data please Upgrade to Premium
